Procter & Gamble Company (The) $PG Holdings Decreased by Vest Financial LLC

Vest Financial LLC trimmed its stake in shares of Procter & Gamble Company (The) (NYSE:PG) by 2.1% during the third quarter, HoldingsChannel.com reports. The firm owned 410,684 shares of the company’s stock after selling 8,952 shares during the quarter. Vest Financial LLC’s holdings in Procter & Gamble were worth $59,664,000 as of its most recent filing with the SEC.

A number of other institutional investors have also added to or reduced their stakes in the stock. Mowery & Schoenfeld Wealth Management LLC bought a new position in Procter & Gamble in the 2nd quarter worth about $26,000. Montgomery Financial Services LLC bought a new stake in shares of Procter & Gamble during the second quarter valued at about $28,000. Paladin Partners LLC bought a new stake in shares of Procter & Gamble during the second quarter valued at about $29,000. Toews Corp ADV purchased a new stake in shares of Procter & Gamble in the second quarter worth about $37,000. Finally, Evergreen Advisors LLC bought a new position in Procter & Gamble in the 1st quarter valued at $37,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Price Performance

PG opened at $156.97 on Thursday. The company has a current ratio of 0.68, a quick ratio of 0.47 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $364.58 billion, a P/E ratio of 23.71, a PEG ratio of 3.96 and a beta of 0.39. The stock has a 50-day moving average price of $147.65 and a 200-day moving average price of $146.83. Procter & Gamble Company has a 12-month low of $137.62 and a 12-month high of $167.25.

Procter & Gamble (NYSE:PG) last released its earnings results on Wednesday, July 29th. The company reported $1.43 earnings per share for the quarter, topping analysts’ consensus estimates of $1.41 by $0.02. The company had revenue of $21.20 billion during the quarter, compared to the consensus estimate of $21.38 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. Procter & Gamble’s quarterly revenue was up 1.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. Equities analysts predict that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Investors of record on Friday, October 23rd will be given a $1.0885 dividend. This represents a $4.35 dividend on an annualized basis and a yield of 2.8%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is presently 65.71%.

Insiders Place Their Bets

In other Procter & Gamble news, CAO Matthew Janzaruk sold 359 shares of the company’s stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $145.24, for a total transaction of $52,141.16. Following the completion of the sale, the chief accounting officer directly owned 1,271 shares in the company, valued at $184,600.04. This represents a 22.02% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, insider Marc Pritchard sold 4,030 shares of the firm’s stock in a transaction dated Thursday, August 20th. The shares were sold at an average price of $143.79, for a total value of $579,473.70. Following the transaction, the insider directly owned 187,001 shares in the company, valued at $26,888,873.79. This trade represents a 2.11% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold a total of 15,135 shares of company stock valued at $2,189,970 over the last three months. 0.23% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research firms recently issued reports on PG. TD Cowen reissued a “hold” rating and set a $150.00 price objective on shares of Procter & Gamble in a research note on Wednesday, September 30th. Jefferies Financial Group upped their target price on Procter & Gamble from $177.00 to $179.00 and gave the stock a “buy” rating in a research note on Friday, June 26th. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a report on Monday, September 21st. UBS Group reiterated a “buy” rating on shares of Procter & Gamble in a research report on Friday, October 16th. Finally, Sanford C. Bernstein reiterated a “market perform” rating and set a $149.00 price target on shares of Procter & Gamble in a research report on Monday, August 24th. Fourteen research analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $162.20.

Key Stories Impacting Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Procter & Gamble’s dividend remains a key support for the stock. The company recently recorded its 70th consecutive annual dividend increase, reinforcing its appeal to income-focused investors, particularly while interest rates remain elevated. The Ultimate Dividend Growth Stock to Buy With $100 Right Now
• Positive Sentiment: Royal Bank of Canada reaffirmed its “outperform” rating and maintained a $166 price target, implying additional upside from the referenced trading level. Benzinga analyst-rating report
• Neutral Sentiment: Investors are comparing PG’s dependable profitability and cash flow from essential household products with higher-risk consumer brands such as Nike. This supports PG’s defensive profile but does not provide a new earnings catalyst. Nike vs. Procter & Gamble
• Negative Sentiment: Procter & Gamble expects only 1% to 3% organic sales growth, raising concerns that the company’s large brands may be struggling to generate stronger underlying demand. Procter & Gamble Expects 1% to 3% Organic Growth
• Negative Sentiment: The earnings preview identifies a central risk: recovering product volumes could be offset by pricing headwinds, potentially limiting revenue growth and margins. Procter & Gamble Earnings Preview
• Negative Sentiment: Options-market activity indicates traders are positioned for PG shares to decline following the earnings release, reflecting elevated near-term uncertainty. Barchart Earnings Analysis

Procter & Gamble Company Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.